Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Pluri Inc PLUR

Pluri Inc., formerly known as Pluristem Therapeutics Inc., is an Israel-headquartered company engaged in the research and provision of cell-based products directed for a range of industries. The Company is focused on researching and developing cell transformation and 3D cell expansion technologies that allow mass production of cells. The products of the Company are used for the pharmaceutical industry as well as for food technology, agriculture technology, and cell-based materials. In the pharmaceutical sector, the Company's preclinical and clinical programs explore multiple therapeutic areas such as vascular disease, inflammation-related conditions, muscle injuries, and hematological disorders. In the food sector, the Firm produces cultivated meat, cultivated fish, and seafood, as well as plant-based products. In agriculture, the Company develops alternative farming methods. The Company has a portfolio of over 140 granted patents in approximately 52 countries.


NDAQ:PLUR - Post by User

<< Previous
Bullboard Posts
Next >>
Post by lucaM1on Apr 24, 2022 9:58am
110 Views
Post# 34627149

Israeli Companies Want to Bring Lab-grown Meat to the Masses

Israeli Companies Want to Bring Lab-grown Meat to the Masses

An Israeli biotech company and food giant Tnuva rang the bell at NASDAQ March 28, celebrating their partnership to produce lab-grown meat.

Pluristem Therapeutics and Tnuva joined the race to create meat products from animal cells, using technology they say is more sustainable than natural methods and hoping to meet the demand for cruelty-free alternatives.

Tnuva is investing $7.5 million in the partnership, called NewCo, with an option to invest up to an additional $7.5 million over a year-long period.

Pluristem CEO Yaky Yanay called the initial product “cultured meat” and said it is grown from real meat cells, tissue, fat and muscle. “We’re not talking about a substitute,” Yanay told the New York Jewish Week. “We will be able to provide a product that will be healthy and eventually affordable.”


https://jmoreliving.com/2022/04/22/israeli-companies-want-to-bring-lab-grown-meat-to-the-masses/
<< Previous
Bullboard Posts
Next >>